
Adaptive Biotechnologies Investor Relations Material
Latest events

Q4 2024
Adaptive Biotechnologies
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Adaptive Biotechnologies Corporation
Access all reports
Segment Data
Access more data
Revenue by
Business area
Immune Medicine
Minimal Residual Disease
Expenses by
Financials
Adaptive Biotechnologies Corporation operates as a commercial-stage biotechnology company. It provides immunosequencing and immunodiagnostic solutions. Furthermore the company offers research and development, and customer-focused services primarily to academic, government, pharmaceutical, biotechnology, hospital/clinical laboratories, and other companies in the United States and internationally. It operates in two segments, Adaptive Diagnostics and Adaptive Therapeutics. The company's immune system platform analyzes and interprets T cell and B cell receptor sequencing data.
Key slides for Adaptive Biotechnologies Corporation


Q4 2024
Adaptive Biotechnologies Corporation


43rd Annual J.P. Morgan Healthcare Conference 2025
Adaptive Biotechnologies Corporation
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ADPT
Country
🇺🇸 United States